ArticleFrontiers in medicine2026
Clinical case: successful birth as a result of the transfer of an embryo at the blastocyst stage from an oocyte obtained from a tumoral ovary using the OTO-IVM method.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Preservation of fertility for women of reproductive age with malignant ovarian tumors is a complex issue, as organ-preserving treatment may increase the risk of recurrence. Direct involvement of the ovary in the tumor process significantly limits the possibility of implementing the most effective methods: the stimulation of ovulation and cryopreservation of ovarian tissue due to the risk of contamination by tumor cells. The only possible method of preserving fertility in such cases may be the OTO-IVM (Ovarian tissue oocyte Methods: We present the first case of a successful birth as a result of the implementation of the OTO-IVM fertility preservation program with embryo transfer performed at the blastocyst stage. A 29-year-old female patient with a recurrence of a borderline tumor in a single ovary underwent surgery to preserve the uterus and remove the tumor-affected ovary. Findings: 22 cumulus-oocyte complexes were retrieved from the removed ovary. As a result of OTO-IVM, 12 metaphase II stage oocytes were obtained, which were fertilized using the intracytoplasmic sperm injection (ICSI) method; 3 blastocyst stage embryos were obtained and cryopreserved. The female patient was prescribed cyclic hormone replacement therapy. After 9 months, one embryo was thawed and transferred into the uterine cavity, resulting in clinical pregnancy. Normal delivery by way of natural maternal passages, a healthy boy was born at the term of 37 weeks and 6 days. Discussion: Our work confirms that the OTO-IVM method has high value for preserving fertility in female patients with malignant ovarian tumor. We have shown for the first time that prolonged cultivation of embryos to the blastocyst stage in OTO-IVM programs can lead to live birth. Cultivation to the blastocyst stage makes it possible to conduct preimplantation testing of embryos, which is extremely important for patients with genetically determined forms of cancer. It is necessary to continue research to improve the method and determine the indications and contraindications for its implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.